OCCAM BIO LIMITED
Company number 13048719 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
OCCAM BIO LIMITED - Analysis Report
Company Number: 13048719
Analysis Date: 2025-07-29 14:42 UTC
Risk Rating: LOW
Occam Bio Limited demonstrates a sound financial position with positive net assets and net current assets that have grown steadily year-over-year. The company is compliant with filing deadlines, has minimal current liabilities, and maintains a modest cash balance relative to liabilities, supporting its ability to meet short-term obligations.Key Concerns:
- Related Party Receivables Concentration: A significant portion of current assets (£57,315 out of £64,735) comprise amounts owed by the parent company. This concentration risk means liquidity depends heavily on the parent’s financial health and payment practices.
- Limited Operational Scale: With only two employees and low tangible assets, the company appears to have a small operational footprint, which could limit scalability and revenue diversification.
- Modest Cash Reserves: Cash on hand is relatively low (£16,060) compared to total assets, which may constrain the company’s ability to manage unexpected expenses or invest in growth without additional funding.
- Positive Indicators:
- Strong Net Current Asset Position: Net current assets improved from £53,302 in 2022 to £70,961 in 2023, indicating improved short-term liquidity and working capital management.
- Compliance and Governance: The company is current with all statutory filings including accounts and confirmation statements, suggesting good regulatory compliance and governance discipline.
- Steady Equity Growth: Shareholders’ funds increased from £56,556 to £76,177, reflecting accumulated retained earnings and a strengthening equity base.
- No Audit Requirement and Small Company Status: The company benefits from small company reporting exemptions, reducing administrative burdens and costs.
- Due Diligence Notes:
- Investigate the nature and terms of the related party balances, including the parent company’s financial strength and payment history, to assess risk concentration and liquidity reliability.
- Review revenue streams and contracts to understand business sustainability given the small employee base and limited fixed assets.
- Confirm the company’s cash flow patterns and whether any external financing or capital injections are planned or required.
- Verify directors’ background and any potential conflicts of interest, given the close relationship with the parent entity.
- Assess lease commitments and other contingent liabilities not detailed in current financials.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.